title: [Verapamil versus flunarizine in the preventive therapy of hemicrania].
abstract: In this single-blind, parallel group study, the efficacy of verapamil (240 mg/die) vs flunarizine (10 mg/die) for prophylactic treatment was evaluated in 38 patients (8M and 30F, mean age 34.4 years) with common or classic migraine. During the 3 months study, both drugs were found to be effective in reducing the number and intensity of the attacks. Verapamil showed better safety than flunarizine.
authors: Ospedale Miulli, Casamassima Divisione di Neurologia, Centro per lo Studio delle Cefalee.
authors: M
authors: M
authors: Lastilla
authors: P
authors: P
authors: Achille
authors: M A
authors: MA
authors: Savarese
authors: G
authors: G
authors: Frascella
mesh_terms: D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D005444:Flunarizine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D013997:Time Factors; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014700:Verapamil; D005444:Flunarizine
vernacular_title: Verapamil versus flunarizina nella terapia preventiva dell'emicrania.